Overview
EpSSG (European Soft Tissue Sarcoma Study Group) Protocol for Non-Metastatic Rhabdomyosarcoma in Children
Status:
Unknown status
Unknown status
Trial end date:
1969-12-31
1969-12-31
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of the study is achieve standardization treatment of low and intermediate risk rhabdomyosarcoma patients, with an attempt to improve treatment results in high and very high risk patients by the addition of doxorubicin as induction treatment and at the maintenance phase.Phase:
Phase 4Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Sheba Medical CenterTreatments:
Cyclophosphamide
Doxorubicin
Criteria
Inclusion Criteria:- child
- non metastatic rhabdomyosarcoma
- adequate heart, kidney, liver function
Exclusion Criteria:
- age over 21 years, under 6 months
- metastatic disease
- heart, kidney, liver disease